These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9832247)
21. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Liu W; Morrow JD; Yin H Free Radic Biol Med; 2009 Oct; 47(8):1101-7. PubMed ID: 19647073 [TBL] [Abstract][Full Text] [Related]
22. Quantitative metabolic profiling of urinary eicosanoids for clinical phenotyping. Gómez C; Gonzalez-Riano C; Barbas C; Kolmert J; Hyung Ryu M; Carlsten C; Dahlén SE; Wheelock CE J Lipid Res; 2019 Jun; 60(6):1164-1173. PubMed ID: 30842246 [TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of prostanoids in biological fluids by combined capillary column gas chromatography negative ion chemical ionization mass spectrometry. Waddell KA; Barrow SE; Robinson C; Orchard MA; Dollery CT; Blair IA Biomed Mass Spectrom; 1984 Feb; 11(2):68-74. PubMed ID: 6722282 [TBL] [Abstract][Full Text] [Related]
24. [Progress in the technology of prostaglandin isolation and analysis (prostaglandins, thromboxanes, and leukotrienes)]. Kobayashi T; Sakurai H Nihon Rinsho; 1985 Mar; 43(3):608-14. PubMed ID: 3892093 [No Abstract] [Full Text] [Related]
25. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatography-mass spectrometry. Tsukamoto H; Hishinuma T; Mikkaichi T; Nakamura H; Yamazaki T; Tomioka Y; Mizugaki M J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 774(2):205-14. PubMed ID: 12076690 [TBL] [Abstract][Full Text] [Related]
26. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Walter MF; Blumberg JB; Dolnikowski GG; Handelman GJ Anal Biochem; 2000 Apr; 280(1):73-9. PubMed ID: 10805523 [TBL] [Abstract][Full Text] [Related]
27. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine. Schwedhelm E; Tsikas D; Durand T; Gutzki FM; Guy A; Rossi JC; Frölich JC J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):99-112. PubMed ID: 10985571 [TBL] [Abstract][Full Text] [Related]
28. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. Nourooz-Zadeh J; Gopaul NK; Barrow S; Mallet AI; Anggård EE J Chromatogr B Biomed Appl; 1995 May; 667(2):199-208. PubMed ID: 7663692 [TBL] [Abstract][Full Text] [Related]
29. A review of analytical methods for eicosanoids in brain tissue. Puppolo M; Varma D; Jansen SA J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():50-64. PubMed ID: 24685838 [TBL] [Abstract][Full Text] [Related]
30. Quantification of prostanoids in biological fluids by high resolution gas chromatography-triple stage quadrupole mass spectrometry (GC/MS/MS). Schweer H; Grössl D; Gund S; Soeding K; Seyberth HW Prog Clin Biol Res; 1989; 301():107-11. PubMed ID: 2798441 [No Abstract] [Full Text] [Related]
31. Affinity chromatography as a method for sample preparation in gas chromatography/mass spectrometry. Tsikas D J Biochem Biophys Methods; 2001 Oct; 49(1-3):705-31. PubMed ID: 11694312 [TBL] [Abstract][Full Text] [Related]
32. Profiling prostaglandins, thromboxanes and hydroxy fatty acids using stable isotope dilutions and gas chromatography-mass spectrometry. Gleispach H; Malle E; Dadak C; Hohenester E; Wurm H; Leis HJ Prog Clin Biol Res; 1987; 242():7-12. PubMed ID: 3313423 [No Abstract] [Full Text] [Related]
33. Development of quantitative analysis of plasma thromboxane B2 by gas chromatography-mass spectrometry. Tada M; Matsuda H; Kuzuya T; Inui M; Abe H Jpn Circ J; 1985 Mar; 49(3):276-83. PubMed ID: 3856693 [TBL] [Abstract][Full Text] [Related]
34. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621 [TBL] [Abstract][Full Text] [Related]
35. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry. Yen HC; Wei HJ; Lin CL Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589 [TBL] [Abstract][Full Text] [Related]
36. Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Schwedhelm E; Böger RH Clin Chem Lab Med; 2003 Dec; 41(12):1552-61. PubMed ID: 14708879 [TBL] [Abstract][Full Text] [Related]
37. Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. Bessard J; Cracowski JL; Stanke-Labesque F; Bessard G J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):333-43. PubMed ID: 11339277 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane B2 and 11-dehydrothromboxane B2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry. Uedelhoven WM; Meese CO; Weber PC J Chromatogr; 1989 Dec; 497():1-16. PubMed ID: 2625446 [TBL] [Abstract][Full Text] [Related]
39. Extraction and measurement of prostanoids and isoprostanes: Introduction to Part II. Patrignani P Methods Mol Biol; 2010; 644():147-52. PubMed ID: 20645171 [TBL] [Abstract][Full Text] [Related]
40. Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. Tsikas D; Gutzki FM; Böhme M; Fuchs I; Frölich JC J Chromatogr A; 2000 Jul; 885(1-2):351-9. PubMed ID: 10941682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]